Gynaecomastia and breast cancer in men

BMJ

Volumn 336, Issue 7646, 2008, Pages 709-713

  Niewoehner, Catherine B ^a   Schorer, Anna E ^b  

^a VA MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; AMIODARONE; ANABOLIC AGENT; ANDROGEN; ANTIANDROGEN; ANTIRETROVIRUS AGENT; BICALUTAMIDE; CHORIONIC GONADOTROPIN; CIMETIDINE; CLOMIFENE; CYPROTERONE; DIAZEPAM; DIETHYLSTILBESTROL; DIGITALIS; DUTASTERIDE; ESTROGEN; FINASTERIDE; FLUTAMIDE; GONADORELIN AGONIST; KETOCONAZOLE; LAVENDER OIL; METRONIDAZOLE; NILUTAMIDE; PHENYTOIN; RANITIDINE; SPIRONOLACTONE; STEROID 5ALPHA REDUCTASE INHIBITOR; TEA TREE OIL; TESTOSTERONE; UNINDEXED DRUG;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER DIAGNOSIS; CANCER SURGERY; DRUG EFFECT; GYNECOMASTIA; HORMONAL REGULATION; HUMAN; MALE; PRIORITY JOURNAL; REVIEW;

ADULT; BREAST NEOPLASMS, MALE; GYNECOMASTIA; HORMONES; HUMANS; MALE; RISK FACTORS;

EID: 41649087796     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39511.493391.BE     Document Type: Review

References (24)

1. Nuttall FQ. Gynecomastia as a physical finding in normal men. J Clin Endocrinol Metab 1979;48:338-40.
2. Niewoehner CB, Nuttall FQ. Gynecomastia in a hospitalized male population. Am J Med 1984;77:633-7.
3. Andersen JA, Gram JB. Male breast at autopsy. Acta Path Microbiol Immunol Scand 1982;90:191-7.
4. Friedl KE, Yesalis, CE. Self-treatment of gynecomastia in bodybuilders who use anabolic steroids. case reports. Physician Sports Med 1989;17:67-79.
5. Dobs B, Darkes MJM. Incidence and management of gynecomastia in men treated for prostate cancer. J Urol 2005;174:1737-42.
6. Allen EA, Parwant AV, Siddiqui MT, Clark DP, Ali SZ. Cytopathologic findings in breast tissues in men with HIV infection. Acta Cytologica 2003;47:183-7.
7. Henley DV, Lipson N, Korach KS, Bloch CA. Pubertal gynecomastia linked to lavender and tea tree oils. N Engl J Med 2007;356:479-85.
8. Tseng A, Horning SJ, Freiha FS, Resser KJ, Hannigan JF, Torti FM. Gynecomastia in testicular cancer patients. Cancer 1985;56:2534-8.
9. Shozu M, Sebastian S, Takayama K, Hsu W-T, Schultz RA, Neely K, et al. Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene. N Engl J Med 2003;348:1855-65.
10. Sasco AJ, Lowenfels AB, Pasker-de Jong P. Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 1993;53:538-49.
11. Swerdlow AJ, Schoemaker MJ, Higgins CD, Wright AF, Jacobs PA. Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study. J Natll Cancer Inst 2005;97(16):1204-10
12. Karlsson CT, Malmer B, Wiklund F, Gronberg H. Breast cancer as a second primary in patients with prostate cancer - estrogen treatment or association with family history of cancer? J Urol 2006 Aug;176(2):538-43.
13. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997;336:1401-8.
14. Weiss JR, Moysich KB, Swede H. Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev 2005;14:20-6.
15. Evans GFF, Anthony T, Appelbaum AH, Schumpert TD, Levy KR, Amirkhan RH, et al. The diagnostic accuracy of mammography in the evaluation of male breast disease. Am J of Surg 2001;181:96-100.
16. Anderson WF, Devesa SS. In situ breast carcinoma in the surveillance, epidemiology, and end results database of the National Cancer Institute. Cancer 2005;104:1733-41.
17. Dobs AS, Meikle AW, Arver S, Sanders SW, Carmelli KE, Mazer NA. Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. J Clin Endocrinol Metab 1999;84:3469-78.
18. Lawrence SE, Faught KA, Vethamuthu J, Lawson ML. Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. J Pediatrics 2004;145:71-6.
19. Boccardo F, Rubagotti A, Battaglia M, Di Tonno P, Selvaggi FP, Conti G, et al. Evaluation of tamoxifen and anastrazole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer. J Clin Oncol 2005;23:808-15.
20. Plourde PV, Reite FQ, Jou HC, Desrochers PE, Rubin SD, Bercu BB, et al. Safety and efficacy of anastrazole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2004;89:4428-33.
21. Perdonna S, Autorino R, De Placido S, D'Armiento M, Gallo A, Damiano R, et al. Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomized, controlled trial. Lancet Oncol 2005;6:295-300.
22. Fruhstorfer BH, Malata CM. A systematic approach to the surgical treatment of gynecomastia. Br J Plast Surg 2003;56:237-46.
23. Goes JC, Landecker A. Ultrasound-assisted lipoplasty (UASL) in breast surgery. Aesthetic Plast Surg 2002;26:1-9.
24. Ribeiro GG, Swindell R, Harris M, Banerjee S, Cramer A. A review of the management of male breast carcinoma based on an analysis of 420 treated cases. Breast 1996;5:141-6.